• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

AIDS Group Says ACA Plan Copay Accumulators are More Common Than Not

Publication
Article
MHE PublicationMHE May 2021
Volume 31
Issue 5

Copay accumulators are a common feature in health insurance plans sold on the ACA exchanges, according to a recent report from an AIDS advocacy group that wants the Biden administration to reverse a decision made by the Trump administration that allowed continued use of accumulators.

Copay accumulators are a common feature in health insurance plans sold on the ACA exchanges, according to a recent report from an AIDS advocacy group that wants the Biden administration to reverse a decision made by the Trump administration that allowed continued use of accumulators.

The AIDS Institute issued a report in March that says that at least two-thirds of the ACA health plans in 35 states include a copay accumulator and that in 14 states, every plan does.

Copay accumulators remove any copay assistance that members receive from spending that would count toward a health plan’s deductible. Patient advocacy groups say accumulators undermine copay assistance and protection against the high cost of drugs. And the AIDS Institute says in its report that they doubly benefit insurers and PBMs because they receive the copay assistance funds and then the amount the member spends until the plan’s out-of-pocket maximum is reached. The counterargument from insurers and PBMs is that accumulators sabotage formularies and wind up making healthcare and premiums more expensive.

Last year, the Trump administration moved to limit accumulators and then reversed course. The AIDS Institute wants the Biden administration to change the Trump administration’s policy and rein in the use of accumulators.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.